FTC Review Of CVS’ Eckerd Store Acquisition Extended
This article was originally published in The Pink Sheet Daily
Executive Summary
CVS refiled its notice of intent to acquire a portion of the Eckerd drug store chain to allow Federal Trade Commission staff additional time for review, the company said May 14
You may also be interested in...
CVS Doubles PBM Business Through $2.2 Bil. Eckerd Deal
CVS sees the acquisition of Eckerd Health Services as key to luring larger corporate PBM customers. The acquisition of 1,260 Eckerd pharmacies also makes CVS the number one U.S. pharmacy retailer in store count, with over 5,000 outlets.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.